173 related articles for article (PubMed ID: 34344784)
21. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
[TBL] [Abstract][Full Text] [Related]
22. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).
Lee JWJ; Zhu F; Srivastava S; Tsao SK; Khor C; Ho KY; Fock KM; Lim WC; Ang TL; Chow WC; So JBY; Koh CJ; Chua SJ; Wong ASY; Rao J; Lim LG; Ling KL; Chia CK; Ooi CJ; Rajnakova A; Yap WM; Salto-Tellez M; Ho B; Soong R; Chia KS; Teo YY; Teh M; Yeoh KG
Gut; 2022 May; 71(5):854-863. PubMed ID: 33975867
[TBL] [Abstract][Full Text] [Related]
23. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
24. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349
[TBL] [Abstract][Full Text] [Related]
25. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
Kodama M; Murakami K; Okimoto T; Abe H; Sato R; Ogawa R; Mizukami K; Shiota S; Nakagawa Y; Soma W; Arita T; Fujioka T
Scand J Gastroenterol; 2013 Nov; 48(11):1249-56. PubMed ID: 24079881
[TBL] [Abstract][Full Text] [Related]
26. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
[TBL] [Abstract][Full Text] [Related]
28. Long-term proton pump inhibitor use and gastrointestinal cancer.
Graham DY; Genta RM
Curr Gastroenterol Rep; 2008 Dec; 10(6):543-7. PubMed ID: 19006608
[TBL] [Abstract][Full Text] [Related]
29. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
30. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for gastric cancer: is it time to discard PPIs?
Laterza L; Scaldaferri F; Gasbarrini A
Gut; 2019 Jan; 68(1):176-177. PubMed ID: 29331945
[No Abstract] [Full Text] [Related]
32. By the way, doctor. I was treated for two weeks with antibiotics and a proton pump inhibitor when I had an H.pylori infection. I've continued with the proton inhibitor to cut down on stomach acid. Could that be harmful?
Komaroff AL
Harv Health Lett; 2008 Jul; 33(9):8. PubMed ID: 18777657
[No Abstract] [Full Text] [Related]
33. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis.
Chen LW; Chang LC; Hua CC; Hsieh BJ; Chen SW; Chien RN
BMC Gastroenterol; 2017 Jan; 17(1):1. PubMed ID: 28049442
[TBL] [Abstract][Full Text] [Related]
34. Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil.
Fox JG; Kuipers EJ
Gut; 2011 May; 60(5):567-8. PubMed ID: 21330575
[No Abstract] [Full Text] [Related]
35. Proton pump inhibitors and H. pylori infection: why the concern?
Weinstein WM
Curr Gastroenterol Rep; 1999 Dec; 1(6):507-10. PubMed ID: 10980994
[TBL] [Abstract][Full Text] [Related]
36. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
Gao W; Huang Y; Lu S; Li C
Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
[TBL] [Abstract][Full Text] [Related]
37. Experimental strategies for induction of gastric adenocarcinomas under long-term proton pump inhibitor administration and Helicobacter pylori infection.
Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
Asian Pac J Cancer Prev; 2012; 13(6):3005-6. PubMed ID: 22938497
[No Abstract] [Full Text] [Related]
38. Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan.
Uno Y
Cancer Med; 2019 Jul; 8(8):3992-4000. PubMed ID: 31119891
[TBL] [Abstract][Full Text] [Related]
39. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
40.
Yoon H; Kim SG; Kim BK; Shin E; Kim N; Lee HJ; Kang GH; Jung HC
Gut Liver; 2017 Jan; 11(1):79-86. PubMed ID: 27282269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
